|
2025
|
G/S
|
Iron preparations for pharmaceutical and veterinary use as well as iron preparations as food supp... |
|
2024
|
G/S
|
Pharmaceuticals, medical and veterinary preparations; Hygienic preparations for medical purposes;... |
|
|
Invention
|
Stable iron oligosaccharide compound.
The invention relates to an iron oligosaccharide compound ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of iron deficiency, anaemia, and iro... |
|
|
G/S
|
Iron preparations for pharmaceutical and veterinary use and iron preparations as food supplement;... |
|
|
Invention
|
Iron complex compounds for theraputic use.
The present invention relates to iron complex compoun... |
|
2023
|
Invention
|
Combination treatments in difficult to treat patients with advanced and/or metastatic trop-2 over... |
|
|
G/S
|
Education; providing of training; entertainment; sporting
and cultural activities; arranging and... |
|
|
Invention
|
Treating iron deficiency with ferric carboxymaltose.
The present invention relates to the field ... |
|
|
G/S
|
Iron preparations for pharmaceutical and veterinary use as
well as iron preparations as food sup... |
|
|
Invention
|
Transient protection of normal cells during chemotherapy.
This invention is in the area of impro... |
|
|
Invention
|
Synthesis of 1,4-diazaspiro[5.5]undecan-3-one.
This invention provides a process for preparing 1... |
|
|
G/S
|
Iron preparations for pharmaceutical use for the treatment of iron deficiency in humans |
|
|
G/S
|
Iron preparations for pharmaceutical use for the treatment
of iron deficiency in humans. |
|
|
Invention
|
Cyclin-dependent kinase inhibiting compounds for the treatment of medical disorders.
This invent... |
|
|
G/S
|
Chemicals for use in industry and science; adhesives for use in industry; biological preparations... |
|
|
G/S
|
Chemicals for use in industry and science; adhesives for use
in industry; biological preparation... |
|
|
Invention
|
Cdk inhibitors.
Compounds of Formulae I, II or III, and pharmaceutically acceptable salts thereo... |
|
|
Invention
|
Hspc-sparing treatments for rb-positive abnormal cellular proliferation.
This invention is in th... |
|
2022
|
G/S
|
Pharmaceutical preparations; veterinary preparations; dietary supplements for human beings; dieta... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of iron deficiency and/or anaemia or... |
|
|
G/S
|
Pharmaceutical preparations; veterinary preparations;
dietary supplements for human beings; diet... |
|
|
Invention
|
Preservation of immune response during chemotherapy regimens.
The addition of a selective, fast-... |
|
|
G/S
|
Medical preparations; pharmaceuticals; veterinary preparations; dietary supplements for human bei... |
|
|
G/S
|
Chemicals for use in industry and science, adhesives for use in industry, biological preparations... |
|
|
G/S
|
Pharmaceuticals for the treatment and/or prevention of iron deficiency and/or anaemia or of iron ... |
|
|
G/S
|
Medical preparations; pharmaceuticals; veterinary
preparations; dietary supplements for human be... |
|
|
G/S
|
Chemicals for use in industry and science, adhesives for use
in industry, biological preparation... |
|
|
G/S
|
Glucose for industrial purposes; glucose derivatives for industrial purposes; glucose oligo- and ... |
|
|
Invention
|
Cryoprotecting agent, cryoprotecting and cryopreserved compositions, uses thereof, and methods of... |
|
|
Invention
|
Highly active anti-neoplastic and anti-proliferative agents.
This invention is in the area of im... |
|
|
Invention
|
Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals. T... |
|
|
Invention
|
Treatment of egfr-driven cancer with fewer side effects.
The present invention provides methods ... |
|
|
Invention
|
G1t38 superior dosage regimes.
A G1T38 human oral dosage regime that provides a (mean AUC(0-24),... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of iron deficiency and/or anaemia or... |
|
|
Invention
|
Substituted 1′,2′-dihydro-3′h-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c][1,2,4]tria... |
|
|
Invention
|
Targeted treatment of cancers with dysregulated fibroblast growth factor receptor signaling.
The... |
|
|
G/S
|
Dietary supplements and dietetic preparations; Diagnostic preparations and materials; Adjuvants f... |
|
|
Invention
|
Morphic forms of g1t38 and methods of manufacture thereof. This invention provides an unexpectedl... |
|
2021
|
Invention
|
Patient selection for enhancement of anti-tumor immunity in cancer patients.
A method for increa... |
|
|
Invention
|
Treatment of rb-negative tumors using topoisomerase inhibitors in combination with cyclin depende... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of iron deficiency anaemia; veterinary preparations... |
|
|
G/S
|
Pharmaceutical preparations; veterinary preparations;
dietary supplements for human beings and a... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of iron deficiency anaemia in humans; pharmaceutica... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of iron deficiency anaemia in humans; veterinary ph... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of iron deficiency anaemia in humans; veterinary pr... |
|
|
G/S
|
Iron preparations for pharmaceutical use for treating iron deficiency in humans |
|
|
Invention
|
Morphic forms of trilaciclib and methods of manufacture thereof. An advantageous isolated morphic... |
|
|
Invention
|
Transient protection of normal cells during chemotherapy. This invention is in the area of improv... |
|
|
Invention
|
Treatment or prevention of anaemia in pregnant non-human mammals.
The present invention relates ... |
|
|
G/S
|
Iron preparations for pharmaceutical use for treating iron deficiency in humans; none of the fore... |
|
|
Invention
|
Treating iron deficiency with ferric carboxymaltose. The present invention relates to the field o... |
|
|
Invention
|
Synthesis of 1,4-diazaspiro[5.5]undecan-3-one. This invention provides a process for preparing 1,... |
|
|
Invention
|
Iron carbohydrate complex for treatment of restless leg syndrome (rls). The present invention rel... |
|
|
Invention
|
Hspc-sparing treatments for rb-positive abnormal cellular proliferation. This invention is in the... |
|
|
Invention
|
Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant. Disclosed her... |
|
|
G/S
|
Dietary and nutritional supplements to support iron levels and to treat iron-deficiency anemia; d... |
|
|
Invention
|
Stable iron oligosaccharide compound. The invention relates to an iron oligosaccharide compound w... |
|
2020
|
Invention
|
Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines. This invention is in the area of sy... |
|
|
G/S
|
Iron preparations for pharmaceutical and veterinary use; iron preparations as food supplements |
|
|
G/S
|
Cryoprotectants in the nature of carbohydrates in solid, liquid or gas state for use in storing, ... |
|
|
G/S
|
Cryoprotectants in the nature of carbohydrates in solid,
liquid or gas state for use in storing,... |
|
|
Invention
|
G1t38 superior dosage regimes. A G1T38 human oral dosage regime that provides a (mean AUC(0-24),s... |
|
|
Invention
|
Treating iron deficiency in subjects at risk of cardiovascular adverse events. The present invent... |
|
|
Invention
|
Cdk inhibitors. Compounds of Formulae I, II or III, and pharmaceutically acceptable salts thereof... |
|
|
Invention
|
Benzothiophene estrogen receptor modulators. This invention is a benzothiophene estrogen receptor... |
|
|
Invention
|
Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the ma... |
|
2019
|
Invention
|
Treatment of egfr-driven cancer with fewer side effects. The present invention provides methods f... |
|
|
Invention
|
Combination therapy for treatment of cancer. Compositions, combinations and methods comprising a ... |
